Zawya13h
University of Dubai confirms its second MSI 20000 certification cycle, for the quality of its financial governance
University of Dubai confirms its second MSI 20000 certification cycle, for the quality of its financial governance ...
PharmiWeb13h
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...
RTX 50 GPUs won't suffer a repeat of melting 4090 power cables, Nvidia claims
Nvidia recently reassured customers that its upcoming RTX 50 series graphics cards won't repeat the controversy from two years ago when the flagship RTX 4090 power ...
Le Lézard7h
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
Agenus Inc. , a leader in immuno-oncology, today shared new data on botensilimab (BOT) and balstilimab (BAL) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) ...
Where to buy the Nvidia RTX 5090: the hotly-awaited Founders Edition GPUs and chunky third-party cards are already listed at retailers
Whether from Nvidia, MSI, Gigabyte, Asus, or another, here are the places to shop for an RTX 5090 on January 30.
PCMag on MSN15h
Is Your Android VPN Safe? Here's a New Way to Check
Google Play finally rolls out badges on VPN apps that appear if an app has passed an independent security review.
Nvidia says melting power connectors are a thing of the past
Nvidia is confident there will be no melting connectors thanks to the 12V-2x6 standard featured on its RTX 50-series GPUs.
TweakTown20h
NASA releases jaw-dropping 2.5 billion pixel image that took 10 years to capture
The Hubble Space Telescope has used its sensitive instruments to create a mosaic image containing 2.5 billion of the Milky Way's closest neighbor.
Le Lézard14h
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today provided details from the abstracts featuring pelareorep ...